Basic and diluted earnings (loss) per share is calculated based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings (loss) per share. A reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share follows (dollars in millions, except per share amounts; shares in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025

Numerator:
Net income (loss) attributable to Surgery Partners, Inc.	$	(15.0)	$	(2.5)	$	(50.9)	$	(40.2)



Denominator:
Weighted average common shares outstanding:
Basic	128,825		126,980		128,597		126,792
Diluted (1)	128,825		126,980		128,597		126,792

Net income (loss) per share attributable to common stockholders:
Basic	$	(0.12)	$	(0.02)	$	(0.40)	$	(0.32)
Diluted (1)	$	(0.12)	$	(0.02)	$	(0.40)	$	(0.32)

Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive:
Stock options	126		875		135		911
Restricted shares	272		183		286		208